Eastman Chemical Company (EMN) faced a disappointing third quarter, with an 11% year-over-year revenue drop to $2.2 billion, missing analyst expectations. Despite this downturn and a 41% stock value decline over the past year, the company announced a quarterly dividend increase, marking its 16th consecutive rise, while simultaneously planning to cut structural costs by over $75 million. EMN aims to navigate these challenges and forecasted a long-term revenue growth of $9.6 billion by 2028.